Search

Sally D John

from Roslindale, MA
Age ~61
Get Report
Also known as:
Sarah John, John Morton Sally, Sally Morton, Sally Johnmie, John D Sally, John Sallyd
Phone and address:
20 Greenock St, Boston, MA 02124
Related to:
Marcia L John, 54Barbara A John, 73Robert John, 58Mclean M John, 96George John, 69
Connected to:
Abbott V John, 70Aisha John, 29Aiyana S John, 39Akshay A John, 27Alford A John, 41Aloysius John, 32Ana L John, 66Andy S John, 55Angeline John, 53Anil John, 57

Sally John Phones & Addresses

  • 20 Greenock St, Boston, MA 02124
  • Roslindale, MA
  • Brooklyn, NY
  • New York, NY

Publications

Isbn (Books And Publications)

A Journey by Chance

View page
Author

Sally D. John

ISBN #

0736908803

After All These Years

View page
Author

Sally D. John

ISBN #

0736908811

In a Heartbeat

View page
Author

Sally D. John

ISBN #

0736911693

Flash Point

View page
Author

Sally D. John

ISBN #

0736913149

Surrender of the Heart

View page
Author

Sally D. John

ISBN #

0786227117

To Dream Again

View page
Author

Sally D. John

ISBN #

0786240881

In the Shadow of Love

View page
Author

Sally D. John

ISBN #

0891079831

The Sally and Tommy John Story

View page
Author

Sally John

ISBN #

0025592602

Us Patents

Biomarkers For Serious Skin Rash

View page
US Patent:
20100120049, May 13, 2010
Filed:
Nov 10, 2009
Appl. No.:
12/615944
Inventors:
Aris FLORATOS - Astoria NY, US
Sally L. JOHN - New London CT, US
Matthew R. NELSON - Chapel Hill NC, US
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
The present invention provides a method for predicting the risk of a patient for developing adverse drug reactions, particularly Serious Skin Rash (SSR), including such severe adverse reactions such as Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). The invention also provides a method of identifying a subject afflicted with or at risk of developing SSR. In some aspects, the methods comprise analyzing at least one genetic marker, wherein the presence of the at least one genetic marker indicates that the subject is afflicted with or at risk of developing SSR. Genetic markers useful in accordance with the methods of the invention are disclosed.

Biomarkers For Drug-Induced Elongated Qt Interval And Torsades De Pointes

View page
US Patent:
20110237456, Sep 29, 2011
Filed:
Mar 24, 2011
Appl. No.:
13/070884
Inventors:
Aris FLORATOS - Astoria NY, US
Matthew R. NELSON - Chapel Hill NC, US
Sally L. JOHN - New London CT, US
International Classification:
C40B 30/04
C12Q 1/68
G01N 33/48
H01J 49/26
US Classification:
506 9, 435 61, 436 94, 250282
Abstract:
The present invention provides a method for predicting the risk of a patient for developing adverse drug reactions, particularly drug-induced prolonged QT interval or TdP. The invention also provides a method of identifying a subject afflicted with, or at risk of, developing TdP. In some aspects, the methods comprise analyzing at least one genetic marker, wherein the presence of the at least one genetic marker indicates that the subject is afflicted with, or at risk of, developing TdP.

Biomarkers For Drug-Induced Liver Injury

View page
US Patent:
20100035265, Feb 11, 2010
Filed:
Jul 17, 2009
Appl. No.:
12/505058
Inventors:
Aris FLORATOS - Astoria NY, US
Sally L. JOHN - New London CT, US
Matthew Roberts NELSON - Chapel Hill NC, US
Ann K. DALY - Newcastle upon Tyne, GB
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
The present invention provides a method for predicting the risk of a patient for developing adverse drug reactions, particularly Drug-Induced Liver Injury (DILI) or hepatotoxicity. The invention also provides a method of identifying a subject afflicted with, or at risk of, developing DILI. In some aspects, the methods comprise analyzing at least one genetic marker, wherein the presence of the at least one genetic marker indicates that the subject is afflicted with, or at risk of, developing DILI.
Control profile
Sally D John from Roslindale, MA, age ~61 Get Report